Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2007 1
2009 2
2011 2
2012 2
2013 1
2015 7
2016 4
2017 1
2018 1
2019 2
2020 2
2021 2
2022 4
2023 5
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Results by year

Filters applied: . Clear all
Page 1
Zanubrutinib or Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia.
Brown JR, Eichhorst B, Hillmen P, Jurczak W, Kaźmierczak M, Lamanna N, O'Brien SM, Tam CS, Qiu L, Zhou K, Simkovic M, Mayer J, Gillespie-Twardy A, Ferrajoli A, Ganly PS, Weinkove R, Grosicki S, Mital A, Robak T, Osterborg A, Yimer HA, Salmi T, Wang MD, Fu L, Li J, Wu K, Cohen A, Shadman M. Brown JR, et al. Among authors: mital a. N Engl J Med. 2023 Jan 26;388(4):319-332. doi: 10.1056/NEJMoa2211582. Epub 2022 Dec 13. N Engl J Med. 2023. PMID: 36511784 Clinical Trial.
Zanubrutinib Versus Ibrutinib in Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma: Interim Analysis of a Randomized Phase III Trial.
Hillmen P, Eichhorst B, Brown JR, Lamanna N, O'Brien SM, Tam CS, Qiu L, Kazmierczak M, Zhou K, Šimkovič M, Mayer J, Gillespie-Twardy A, Shadman M, Ferrajoli A, Ganly PS, Weinkove R, Grosicki S, Mital A, Robak T, Österborg A, Yimer HA, Salmi T, Ji M, Yecies J, Idoine A, Wu K, Huang J, Jurczak W. Hillmen P, et al. Among authors: mital a. J Clin Oncol. 2023 Feb 10;41(5):1035-1045. doi: 10.1200/JCO.22.00510. Epub 2022 Nov 17. J Clin Oncol. 2023. PMID: 36395435 Free PMC article. Clinical Trial.
Acquired von Willebrand Syndrome.
Mital A. Mital A. Adv Clin Exp Med. 2016 Nov-Dec;25(6):1337-1344. doi: 10.17219/acem/64942. Adv Clin Exp Med. 2016. PMID: 28028990 Free article. Review.
Ibrutinib-induced pyoderma gangrenosum.
Sławińska M, Barańska-Rybak W, Sobjanek M, Wilkowska A, Mital A, Nowicki R. Sławińska M, et al. Among authors: mital a. Pol Arch Med Wewn. 2016 Sep 28;126(9):710-711. doi: 10.20452/pamw.3578. Epub 2016 Sep 28. Pol Arch Med Wewn. 2016. PMID: 27698335 Free article. No abstract available.
COVID-19 - Toward a comprehensive understanding of the disease.
Kowalik MM, Trzonkowski P, Łasińska-Kowara M, Mital A, Smiatacz T, Jaguszewski M. Kowalik MM, et al. Among authors: mital a. Cardiol J. 2020;27(2):99-114. doi: 10.5603/CJ.a2020.0065. Epub 2020 May 7. Cardiol J. 2020. PMID: 32378729 Free PMC article. Review.
Determination and interpretation of MTHFR gene mutations in gynecology and internal medicine.
Undas A, Chojnowski K, Klukowska A, Łętowska M, Mital A, Młynarski W, Musiał J, Podolak-Dawidziak M, Sąsiadek M, Treliński J, Urasiński T, Windyga J, Zdziarska J, Zawilska K. Undas A, et al. Among authors: mital a. Pol Arch Intern Med. 2019 Oct 30;129(10):728-732. doi: 10.20452/pamw.15039. Epub 2019 Oct 30. Pol Arch Intern Med. 2019. PMID: 31670725 Free article. Review. No abstract available.
Mast cell leukemia: clinical and molecular features and survival outcomes of patients in the ECNM Registry.
Kennedy VE, Perkins C, Reiter A, Jawhar M, Lübke J, Kluin-Nelemans HC, Shomali W, Langford C, Abuel J, Hermine O, Niedoszytko M, Gorska A, Mital A, Bonadonna P, Zanotti R, Tanasi I, Mattsson M, Hagglund H, Triggiani M, Yavuz AS, Panse J, Christen D, Heizmann M, Shoumariyeh K, Müller S, Elena C, Malcovati L, Fiorelli N, Wortmann F, Vucinic V, Brockow K, Fokoloros C, Papageorgiou SG, Breynaert C, Bullens D, Doubek M, Ilerhaus A, Angelova-Fischer I, Solomianyi O, Várkonyi J, Sabato V, Rüfer A, Schug TD, Hermans MAW, Fortina AB, Caroppo F, Bumbea H, Gulen T, Hartmann K, Elberink HO, Schwaab J, Arock M, Valent P, Sperr WR, Gotlib J. Kennedy VE, et al. Among authors: mital a. Blood Adv. 2023 May 9;7(9):1713-1724. doi: 10.1182/bloodadvances.2022008292. Blood Adv. 2023. PMID: 36094848 Free PMC article.
[Systemic mastocytosis].
Niedoszytko M, Lange M, Chelminska M, Jaśkiewicz K, Piskosz A, Wasag B, Lewandowski K, Mital A, Renke J, Gruchała-Niedoszytko M, Woźniak M, Babińska A, Jassem E. Niedoszytko M, et al. Among authors: mital a. Pneumonol Alergol Pol. 2005;73(3):239-44. Pneumonol Alergol Pol. 2005. PMID: 16989160 Polish.
Therapeutic properties and safety of recombinant factor VIII and factor IX.
Zdziarska J, Chojnowski K, Klukowska A, Łetowska M, Mital A, Podolak-Dawidziak M, Windyga J, Zawilska K; Working Group on Hemostasis of the Polish Society of Hematologists and Transfusiologists. Zdziarska J, et al. Among authors: mital a. Pol Arch Med Wewn. 2009 Jun;119(6):403-9. Pol Arch Med Wewn. 2009. PMID: 19694223 Free article. Review.
33 results